Seattle Genetics and Millennium Initiate Global Phase III Clinical Trial of …

Filed under: drug treatment centers in massachusetts

BOTHELL, WA & CAMBRIDGE, MA, USA I January 24, 2013 I Seattle Genetics, Inc. (SGEN) and Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (TSE:4502), today announced the … ADCETRIS was granted …
Read more on PipelineReview.com (press release)

221 HELP WANTED

Filed under: drug treatment centers in massachusetts    Read more...